Literature DB >> 26289803

[Pulmonary Langerhans cell histiocytosis].

H H Popper1.   

Abstract

Pulmonary Langerhans cell histiocytosis is regarded as a reactive proliferation of the dendritic Langerhans cell population stimulated by chronic tobacco-derived plant proteins due to incomplete combustion but can also occur in childhood as a tumor-like systemic disease. Currently, both these forms cannot be morphologically distinguished. In the lungs a nodular proliferation of Langerhans cells occurs in the bronchial mucosa and also peripherally in the alveolar septa with an accompanying infiltration by eosinophilic granulocytes and destruction of the bronchial wall. Langerhans cells can be selectively detected with antibodies against CD1a and langerin. In the reactive isolated pulmonary form, abstinence from tobacco smoking in most patients leads to regression of infiltration and improvement of symptoms. In high-resolution computed tomography (HRCT) the small star-like scars can still be detected even after complete cessation of tobacco smoking.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26289803     DOI: 10.1007/s00292-015-0052-9

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  52 in total

Review 1.  HISTIOCYTOSIS X (EOSINOPHILIC GRANULOMA OF BONE, LETTERER-SIWE DISEASE, AND SCHUELLER-CHRISTIAN DISEASE). FURTHER OBSERVATIONS OF PATHOLOGICAL AND CLINICAL IMPORTANCE.

Authors:  L LICHTENSTEIN
Journal:  J Bone Joint Surg Am       Date:  1964-01       Impact factor: 5.284

Review 2.  Langerhans cell histiocytosis and Erdheim-Chester disease.

Authors:  Marta Wilejto; Oussama Abla
Journal:  Curr Opin Rheumatol       Date:  2012-01       Impact factor: 5.006

3.  EOSINOPHILIC GRANULOMA OF BONE WITH DIFFUSE PULMONARY INVOLVEMENT.

Authors:  D D Dickson
Journal:  Calif Med       Date:  1948-07

4.  Recurrent RAS and PIK3CA mutations in Erdheim-Chester disease.

Authors:  Jean-François Emile; Eli L Diamond; Zofia Hélias-Rodzewicz; Fleur Cohen-Aubart; Frédéric Charlotte; David M Hyman; Eunhee Kim; Raajit Rampal; Minal Patel; Chezi Ganzel; Shlomzion Aumann; Gladwys Faucher; Catherine Le Gall; Karen Leroy; Magali Colombat; Jean-Emmanuel Kahn; Salim Trad; Philippe Nizard; Jean Donadieu; Valérie Taly; Zahir Amoura; Omar Abdel-Wahab; Julien Haroche
Journal:  Blood       Date:  2014-08-22       Impact factor: 22.113

5.  Use of the JL1 epitope, which encompasses the nonglycosylation site of CD43, as a marker of immature/neoplastic Langerhans cells.

Authors:  Hyo Jin Park; Yoon Kyung Jeon; An Hi Lee; Young-ha Oh; Seong Hoe Park; Kyeong Cheon Jung
Journal:  Am J Surg Pathol       Date:  2012-08       Impact factor: 6.394

6.  Gene expression during differentiation of human dendritic cells from cord blood cd34 stem cells.

Authors:  G M Fisher; S Iqball; S C Knight
Journal:  Cytokine       Date:  1999-02       Impact factor: 3.861

Review 7.  Human mononuclear phagocyte system reunited.

Authors:  Muzlifah Haniffa; Venetia Bigley; Matthew Collin
Journal:  Semin Cell Dev Biol       Date:  2015-05-15       Impact factor: 7.727

8.  Recurrent BRAF mutations in Langerhans cell histiocytosis.

Authors:  Gayane Badalian-Very; Jo-Anne Vergilio; Barbara A Degar; Laura E MacConaill; Barbara Brandner; Monica L Calicchio; Frank C Kuo; Azra H Ligon; Kristen E Stevenson; Sarah M Kehoe; Levi A Garraway; William C Hahn; Matthew Meyerson; Mark D Fleming; Barrett J Rollins
Journal:  Blood       Date:  2010-06-02       Impact factor: 22.113

Review 9.  Histiocytes and histiocytosis.

Authors:  M J Cline
Journal:  Blood       Date:  1994-11-01       Impact factor: 22.113

10.  Pulmonary Langerhans Cell Histiocytosis with Lytic Bone Involvement in an Adult Smoker: Regression following Smoking Cessation.

Authors:  B Routy; J Hoang; J Gruber
Journal:  Case Rep Hematol       Date:  2015-02-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.